The landscape of dementia analysis has evolved considerably with the appearance of sophisticated biomarkers, such as amyloid PET scans, tau imaging, and blood-primarily based exams that may detect Alzheimer's pathology a long time just before signs or symptoms emerge. Although these technological improvements symbolize exceptional progress in understanding neurodegenerative diseases, https://ernestw853qaj2.ssnblog.com/profile